Context Matters: The Importance of a Comprehensive Genomic Region When Assessing the Therapeutic Potential of Antisense Oligonucleotides in Splicing Assays
Nucleic Acid Therapeutics · 2025
DOI: 10.1177/21593337251371582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2025. Verfasst von Dyah W Karjosukarso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, RNA Splicing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Mini/midigene splicing assays are often used to evaluate splicing modulation therapy, for example, employing antisense oligonucleotides (AONs). Twenty-five AONs targeting the splicing defect caused by a recurrent variant in ABCA4 (c.768G>T) were tested using a midigene containing a part of intron 5, exon 6, and a part of intron 6 of the ABCA4 gene. Surprisingly, almost all AONs showed high efficacy, complicating candidate selection. We hypothesized that the lack of genomic context may lead to a very accessible transcript for AONs. Indeed, the use of an ABCA4 maxigene that contains a part of intron 5, exon 6, parts of intron 6, and the genomic region between exons 7 and 11 allowed a clear distinction between efficacious and less efficacious AONs, corroborating the results we recently observed in patient-derived retinal cells. These underscore the necessity of a proper genetic context included in constructs used in splicing assays to assess the potential of splicing modulation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Zitieren
APA
Karjosukarso, D. W., Kiefmann, J. F., Bukkems, F., Duijkers, L., & Collin, R. W. J. (2025). Context Matters: The Importance of a Comprehensive Genomic Region When Assessing the Therapeutic Potential of Antisense Oligonucleotides in Splicing Assays. Nucleic Acid Therapeutics. https://doi.org/10.1177/21593337251371582
Vancouver
Karjosukarso DW, Kiefmann JF, Bukkems F, Duijkers L, Collin RWJ. Context Matters: The Importance of a Comprehensive Genomic Region When Assessing the Therapeutic Potential of Antisense Oligonucleotides in Splicing Assays. Nucleic Acid Therapeutics. 2025. doi:10.1177/21593337251371582
BibTeX
@article{Karjosukarso2025,
author = {Karjosukarso, Dyah W and Kiefmann, Julia F and Bukkems, Femke and Duijkers, Lonneke and Collin, Rob W J},
title = {Context Matters: The Importance of a Comprehensive Genomic Region When Assessing the Therapeutic Potential of Antisense Oligonucleotides in Splicing Assays},
journal = {Nucleic Acid Therapeutics},
year = {2025},
doi = {10.1177/21593337251371582}
}
EUVIMED